Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Tasipimidine by Orion for Insomnia: Likelihood of Approval
Tasipimidine is under clinical development by Orion and currently in Phase II for Insomnia. According to GlobalData, Phase II drugs...